Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
US Army
Queensland Health
Novartis
Cipla
Medtronic
Chubb
Moodys
Baxter
McKinsey

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019778

« Back to Dashboard

NDA 019778 describes PRINZIDE, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the PRINZIDE profile page.

The generic ingredient in PRINZIDE is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Summary for 019778
Tradename:PRINZIDE
Applicant:Merck
Ingredient:hydrochlorothiazide; lisinopril
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 16, 1989TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 16, 1989TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Nov 18, 1993TE:RLD:Yes

Expired US Patents for NDA 019778

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-003 Nov 18, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-001 Feb 16, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-002 Feb 16, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-002 Feb 16, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-003 Nov 18, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-001 Feb 16, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Chubb
Healthtrust
Citi
Colorcon
Teva
Argus Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot